List of Excipients in API NAPHAZOLINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing NAPHAZOLINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | NAPHCON A | naphazoline hydrochloride and pheniramine maleate | 0065-0085 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | NAPHCON A | naphazoline hydrochloride and pheniramine maleate | 0065-0085 | BORIC ACID | |
| Alcon Laboratories Inc | NAPHCON A | naphazoline hydrochloride and pheniramine maleate | 0065-0085 | EDETATE DISODIUM | |
| Alcon Laboratories Inc | NAPHCON A | naphazoline hydrochloride and pheniramine maleate | 0065-0085 | HYDROCHLORIC ACID | |
| Alcon Laboratories Inc | NAPHCON A | naphazoline hydrochloride and pheniramine maleate | 0065-0085 | SODIUM BORATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing NAPHAZOLINE HYDROCHLORIDE
Detailed excipient profiles for NAPHAZOLINE HYDROCHLORIDE
Excipient focus: BENZALKONIUM CHLORIDE
NAPHAZOLINE HYDROCHLORIDE drug variants containing BENZALKONIUM CHLORIDE
NAPHAZOLINE HYDROCHLORIDE drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
NAPHAZOLINE HYDROCHLORIDE drug variants containing BORIC ACID
NAPHAZOLINE HYDROCHLORIDE drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
NAPHAZOLINE HYDROCHLORIDE drug variants containing EDETATE DISODIUM
NAPHAZOLINE HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
NAPHAZOLINE HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
NAPHAZOLINE HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Altaire Pharmaceuticals Inc | naphazoline hydrochloride , pheniramine maleate | 59390-177 |
| Wal-Mart Stores Inc | naphazoline hydrochloride, pheniramine maleate | 49035-874 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
NAPHAZOLINE HYDROCHLORIDE drug variants containing HYPROMELLOSE
NAPHAZOLINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: SODIUM BORATE
NAPHAZOLINE HYDROCHLORIDE drug variants containing SODIUM BORATE
NAPHAZOLINE HYDROCHLORIDE drug variants not containing SODIUM BORATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | naphazoline hydrochloride | 21695-915 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CARBONATE
NAPHAZOLINE HYDROCHLORIDE drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | naphazoline hydrochloride | 21695-915 |
| >Company | >Ingredient | >NDC |
NAPHAZOLINE HYDROCHLORIDE drug variants not containing SODIUM CARBONATE
Excipient focus: SODIUM CHLORIDE
NAPHAZOLINE HYDROCHLORIDE drug variants containing SODIUM CHLORIDE
NAPHAZOLINE HYDROCHLORIDE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | naphazoline hydrochloride and pheniramine maleate | 17478-065 |
| Kenvue Brands LLC | naphazoline hydrochloride and pheniramine maleate | 69968-0367 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
NAPHAZOLINE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
NAPHAZOLINE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
NAPHAZOLINE HYDROCHLORIDE drug variants containing WATER
NAPHAZOLINE HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch